Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cinven
Pharma
CapVest snaps up German generics maker Stada
CapVest Partners is set to pick up a majority stake in Stada in a deal that reportedly values the business at around 10 billion euros ($11.6 billion).
Zoey Becker
Sep 2, 2025 10:12am
German generics maker Stada revives IPO plans: report
Aug 28, 2025 1:00pm
In appeal, Advanz calls UK fine 'manifestly wrong'
Sep 27, 2022 3:48pm
CDMO Lonza will sell its speciality ingredients unit for $4.7B
Feb 9, 2021 8:59am
GSK starts £1B OTC sell-off ahead of Pfizer merger: report
Jun 20, 2019 10:30am
Bain, Cinven raise Stada buyout bid under activist pressure
Sep 5, 2017 10:43am